Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death

Area of Science:

• Cell Biology
• Molecular Oncology
• Reproductive Biology

Background:

• Germ cells, particularly oocytes, are vulnerable to genotoxic chemotherapy agents.
• Chemotherapy-induced ovarian failure and infertility are significant concerns for young cancer patients.

Purpose of the Study:

• To elucidate the c-Abl-TAp63 pathway activated by DNA-damaging drugs.
• To investigate the role of this pathway in germ cell death.
• To explore the potential of targeting this pathway to preserve fertility.

Main Methods:

• Utilized model human cell lines and mouse oocytes.
• Administered cisplatin, a chemotherapeutic agent.
• Employed the c-Abl kinase inhibitor imatinib.
• Analyzed protein phosphorylation, stability, and gene expression.

Main Results:

• Cisplatin treatment induced c-Abl-mediated phosphorylation of TAp63 in cell lines and oocytes.
• This phosphorylation led to TAp63 accumulation and subsequent cell death.
• Imatinib treatment inhibited cisplatin-induced TAp63 modifications and cell death.
• Established a model where c-Abl detects DNA damage and modulates p63 activity.

Conclusions:

• The c-Abl-TAp63 pathway is a key mediator of chemotherapy-induced germ cell death.
• Targeting c-Abl with imatinib may offer a strategy to preserve oocyte reserve during chemotherapy.
• This research suggests a novel therapeutic approach to mitigate infertility in cancer survivors.